Rocket Pharmaceuticals Gene Therapy Investor Deck

Rocket Pharmaceuticals investor presentation detailing gene therapy development programs for rare genetic disorders including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, Danon Disease, and BAG3-associated dilated cardiomyopathy. The deck outlines the company's clinical development strategy and potential therapeutic approaches at the genetic level.